Repositorio Dspace

Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain

Mostrar el registro sencillo del ítem

dc.contributor.author Fernández-de-Larrea-Baz, Nerea
dc.contributor.author Michel, Ángelika
dc.contributor.author Romero, Beatriz
dc.contributor.author Pérez-Gómez, Beatriz
dc.contributor.author Moreno, Víctor
dc.contributor.author Martín, Vicente
dc.contributor.author Dierssen-Sotos, Trinidad
dc.contributor.author Jiménez-Moleon, José-Juan
dc.contributor.author Castilla, Jesús
dc.contributor.author Tardon, Adonina
dc.contributor.author Ruiz, Irune
dc.contributor.author Peiro, Rosana
dc.contributor.author Tejada, Antonio
dc.contributor.author Chirlaque-López, María-Dolores
dc.contributor.author Butt, Julia-A
dc.contributor.author Olmedo-Requena, Rocío
dc.contributor.author Gómez-Acebo, Inés
dc.contributor.author Linares, Pedro
dc.contributor.author Boldo, Elena
dc.contributor.author Castells, Antoni
dc.contributor.author Pawlita, Michael
dc.contributor.author Castaño-Vinyals, Gemma
dc.contributor.author Kogevinas, Manolis
dc.contributor.author de-Sanjose, Silvia
dc.contributor.author Pollan, Marina
dc.contributor.author del-Campo, Rosa
dc.contributor.author Waterboer, Tim
dc.contributor.author Aragonés, Nuria
dc.date.accessioned 2026-01-19T16:08:01Z
dc.date.available 2026-01-19T16:08:01Z
dc.date.issued 2017-05-29
dc.identifier.citation Fernández De Larrea-Baz N, Michel A, Romero B, Pérez-Gómez B, Moreno V, Martín V, et al. Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain. Front Microbiol. 29 de mayo de 2017;8:888.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/23746
dc.description.abstract Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to ?4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results:H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cag? showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.
dc.language.iso eng
dc.publisher FRONTIERS MEDIA SA
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.title Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 28611733
dc.relation.publisherversion http://journal.frontiersin.org/article/10.3389/fmicb.2017.00888/full
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.3389/fmicb.2017.00888
dc.journal.title Frontiers in Microbiology
dc.identifier.essn 1664-302X


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta